A drug that binds to a receptor at a site distinct from the active site and alters the affinity of the receptor for the endogenous ligand is a:-
**Core Concept**
A drug that modulates the activity of a receptor by altering its affinity for the endogenous ligand, without directly interacting with the ligand, is an example of allosteric modulation. This type of modulation involves a distinct binding site, separate from the active site where the endogenous ligand binds.
**Why the Correct Answer is Right**
Allosteric modulation occurs when a drug binds to a receptor at a site distinct from the active site, causing a conformational change that either increases or decreases the receptor's affinity for its endogenous ligand. This type of modulation can be either positive (increasing affinity) or negative (decreasing affinity). Allosteric modulation is a key mechanism by which some drugs exert their effects, particularly in the case of G-protein coupled receptors (GPCRs).
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe allosteric modulation. Allosteric modulation involves a distinct binding site, whereas competitive inhibition involves direct competition with the endogenous ligand for the active site.
**Option B:** This option is incorrect because it is too vague and does not specify the mechanism of action. Allosteric modulation is a specific type of modulation that is distinct from other mechanisms.
**Option C:** This option is incorrect because it describes a different type of receptor modulation, such as agonism or antagonism, which involves direct interaction with the active site.
**Clinical Pearl / High-Yield Fact**
Allosteric modulation is a key mechanism by which some drugs, such as beta blockers and calcium channel blockers, exert their effects on G-protein coupled receptors. Understanding allosteric modulation is essential for understanding the pharmacology of these drugs.
**Correct Answer:** C.